Dr. Stephen John, O.D

NPI: 1275763062
Total Payments
$4,788
2024 Payments
$383.44
Companies
22
Transactions
115
Medicare Patients
3,485
Medicare Billing
$245,017

Payment Breakdown by Category

Food & Beverage$3,546 (74.1%)
Travel$1,190 (24.8%)
Consulting$33.00 (0.7%)
Gifts$19.40 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,546 112 74.1%
Travel and Lodging $1,190 1 24.8%
Consulting Fee $33.00 1 0.7%
Gift $19.40 1 0.4%

Top Paying Companies

Company Total Records Latest Year
Johnson & Johnson Surgical Vision, Inc. $1,689 19 $0 (2022)
Shire North American Group Inc $578.36 23 $0 (2019)
Bausch & Lomb, a division of Bausch Health US, LLC $567.33 16 $0 (2021)
Allergan, Inc. $328.54 7 $0 (2021)
Sun Pharmaceutical Industries Inc. $272.45 6 $0 (2022)
Valeant Pharmaceuticals North America LLC $167.19 6 $0 (2017)
Glaukos Corporation $143.75 2 $0 (2024)
Novartis Pharmaceuticals Corporation $139.34 7 $0 (2023)
Eyevance Pharmaceuticals LLC $134.83 2 $0 (2021)
Alcon Vision LLC $121.41 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $383.44 12 Glaukos Corporation ($127.51)
2023 $160.52 7 ABBVIE INC. ($47.97)
2022 $180.10 8 Novartis Pharmaceuticals Corporation ($44.00)
2021 $453.86 10 Eyevance Pharmaceuticals LLC ($134.83)
2020 $212.22 5 Allergan, Inc. ($103.31)
2019 $1,825 18 Johnson & Johnson Surgical Vision, Inc. ($1,310)
2018 $518.79 14 Johnson & Johnson Surgical Vision, Inc. ($241.56)
2017 $1,054 41 Shire North American Group Inc ($475.78)

All Payment Transactions

115 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/06/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $16.84 General
Category: Inflammation/Rare Disease
10/17/2024 Amgen Inc. TEPEZZA (Biological) Food and Beverage In-kind items and services $28.25 General
Category: Inflammation/Rare Disease
10/10/2024 RxSight Inc RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE Food and Beverage In-kind items and services $28.01 General
Category: OPHTHALMOLOGY
08/26/2024 Tarsus Pharmaceuticals, Inc. XDEMVY (Drug) Food and Beverage In-kind items and services $22.10 General
Category: DEMODEX BLEPHARITIS
08/19/2024 Tarsus Pharmaceuticals, Inc. XDEMVY (Drug) Food and Beverage In-kind items and services $16.14 General
Category: DEMODEX BLEPHARITIS
08/08/2024 Oyster Point Pharma, Inc. TYRVAYA (Drug) Food and Beverage In-kind items and services $25.61 General
Category: Dry eyes
08/08/2024 Dompe US, Inc. OXERVATE (Drug) Food and Beverage In-kind items and services $17.76 General
Category: SOLUTION/ DROPS
07/29/2024 Bausch & Lomb Americas Inc. MIEBO (Drug), XIIDRA Food and Beverage In-kind items and services $24.84 General
Category: Ophthalmology
06/12/2024 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $23.85 General
Category: Ophthalmology
05/30/2024 Oyster Point Pharma, Inc. TYRVAYA (Drug) Food and Beverage In-kind items and services $25.61 General
Category: Dry eyes
05/15/2024 Glaukos Corporation CE-marked KXLA system (Device) Food and Beverage Cash or cash equivalent $127.51 General
Category: Corneal Health
01/29/2024 Tarsus Pharmaceuticals, Inc. XDEMVY (Drug) Food and Beverage In-kind items and services $26.92 General
Category: DEMODEX BLEPHARITIS
12/11/2023 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $23.28 General
Category: Ophthalmology
11/17/2023 Astellas Pharma US Inc Izervay (Drug) Food and Beverage In-kind items and services $18.95 General
Category: Ophthalmology
11/03/2023 ABBVIE INC. LUMIGAN (Drug), ALPHAGAN P Food and Beverage In-kind items and services $29.65 General
Category: EYE CARE
10/22/2023 Oyster Point Pharma, Inc. TYRVAYA (Drug) Food and Beverage In-kind items and services $23.00 General
Category: DRY EYE
09/19/2023 ABBVIE INC. LUMIGAN (Drug), VUITY, ALPHAGAN P Food and Beverage In-kind items and services $18.32 General
Category: EYE CARE
03/20/2023 Oyster Point Pharma, Inc. TYRVAYA (Drug) Food and Beverage In-kind items and services $23.90 General
Category: DRY EYE
02/06/2023 Novartis Pharmaceuticals Corporation XIIDRA (Drug) Food and Beverage In-kind items and services $23.42 General
Category: Ophthalmology
11/03/2022 Johnson & Johnson Vision Care, Inc. Acuvue (Device) Consulting Fee Cash or cash equivalent $33.00 General
Category: Soft Contact Lenses
10/26/2022 Bausch & Lomb Americas Inc. VYZULTA (Drug) Food and Beverage In-kind items and services $19.45 General
Category: Ophthalmology
10/21/2022 Sun Pharmaceutical Industries Inc. Cequa (Drug) Food and Beverage In-kind items and services $22.87 General
Category: Ophthalmology
10/20/2022 RxSight Inc LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) Food and Beverage In-kind items and services $23.41 General
Category: Ophthalmology
07/25/2022 Novartis Pharmaceuticals Corporation XIIDRA (Drug) Food and Beverage In-kind items and services $19.39 General
Category: OPHTHALMOLOGY
06/30/2022 Oyster Point Pharma, Inc. TYRVAYA (Drug) Food and Beverage In-kind items and services $21.00 General
Category: DRY EYE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 824 916 $202,705 $56,313
2022 7 910 989 $230,050 $63,653
2021 7 932 1,016 $244,790 $69,212
2020 8 819 880 $208,035 $55,839
Total Patients
3,485
Total Services
3,801
Medicare Billing
$245,017
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
92014 Established patient complete exam of visual system Office 2023 301 301 $90,300 $24,590 27.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 249 331 $57,925 $19,838 34.2%
92004 New patient complete exam of visual system Office 2023 41 41 $14,350 $3,840 26.8%
92133 Imaging of optic nerve Office 2023 105 106 $16,430 $2,545 15.5%
92083 Exam of visual field with extended testing Office 2023 52 52 $9,100 $2,203 24.2%
92134 Imaging of retina Office 2023 61 70 $10,850 $2,030 18.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 15 15 $3,750 $1,267 33.8%
92014 Established patient complete exam of visual system Office 2022 369 369 $110,700 $29,867 27.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 233 302 $52,850 $18,336 34.7%
92004 New patient complete exam of visual system Office 2022 75 75 $26,250 $7,425 28.3%
92083 Exam of visual field with extended testing Office 2022 56 58 $10,150 $2,467 24.3%
92133 Imaging of optic nerve Office 2022 92 93 $14,415 $2,388 16.6%
92134 Imaging of retina Office 2022 70 77 $11,935 $1,989 16.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 15 15 $3,750 $1,182 31.5%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2021 418 425 $127,500 $35,863 28.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 176 248 $43,305 $16,424 37.9%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Office 2021 95 95 $33,250 $8,463 25.5%
92134 Diagnostic imaging of retina Office 2021 85 89 $13,795 $2,552 18.5%
92133 Diagnostic imaging of optic nerve of eye Office 2021 83 83 $12,865 $2,268 17.6%
92083 Measurement of field of vision during daylight conditions, extended examination Office 2021 45 45 $7,875 $2,238 28.4%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2021 30 31 $6,200 $1,405 22.7%
92014 Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits Office 2020 358 362 $108,600 $31,112 28.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 154 203 $35,525 $9,710 27.3%
92004 Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits Office 2020 58 58 $20,300 $6,011 29.6%
92012 Eye and medical examination for diagnosis and treatment, established patient Office 2020 47 47 $9,400 $2,492 26.5%

About Dr. Stephen John, O.D

Dr. Stephen John, O.D is a Optometrist healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2009. The National Provider Identifier (NPI) number assigned to this provider is 1275763062.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen John, O.D has received a total of $4,788 in payments from pharmaceutical and medical device companies, with $383.44 received in 2024. These payments were reported across 115 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,546).

As a Medicare-enrolled provider, John has provided services to 3,485 Medicare beneficiaries, totaling 3,801 services with total Medicare billing of $245,017. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Optometrist
  • Other Specialties Optometrist
  • Location Marietta, GA
  • Active Since 07/15/2009
  • Last Updated 03/08/2011
  • Taxonomy Code 152W00000X
  • Entity Type Individual
  • NPI Number 1275763062

Products in Payments

  • Tecnis 1-piece IOL (Device) $1,431
  • XIIDRA (Drug) $717.70
  • PROLENSA (Drug) $253.12
  • ULTRA (Device) $181.45
  • Zerviate (Drug) $134.83
  • CE-marked KXLA system (Device) $127.51
  • AcrySof IQ VIVITY IOL (Device) $121.41
  • TYRVAYA (Drug) $119.12
  • CEQUA (Drug) $114.58
  • Tecnis iTec Preloaded Delivery System (Device) $113.18
  • iDesign Advanced Wavescan Studio (Device) $109.92
  • Acuvue (Device) $105.73
  • BIOTRUE (Device) $102.34
  • RESTASIS (Drug) $100.26
  • Cequa (Drug) $99.95
  • MIEBO (Drug) $71.97
  • XDEMVY (Drug) $65.16
  • BIOTRUE ONE DAY (Device) $50.96
  • LUMIGAN (Drug) $47.97
  • TEPEZZA (Biological) $45.09

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Optometrist Doctors in Marietta